Author:
Valentine Chris,Deenmamode Jean,Sherwood Roy
Reference6 articles.
1. In vivo activity against HIV and favourable toxicity profile of 2',3'-dideoxyinosine;Yarchoan;Science,1989
2. 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS related complex;Lambert;N Engl J Med,1990
3. Once daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS related complex;Cooley;N Engl J Med,1990
4. Overview of Phase I trials 2',3'-dideoxyinosine (ddI) conducted on adult patients;Rozencweig;Rev Infect Dis,1990
5. J-P. Aboulker, Cb Valentine, C. Toumene, Jh Darbyshire, An update on the Alpha trial, a study of didanosine (ddI) in symptomatic HIV positive patients intolerant to zidovudine (VIIth International Conference on AIDS (Florence, 1991) abstr 2096).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HIV infection and the pancreas: risk factors and potential management guidelines;International Journal of STD & AIDS;2008-02
2. THE PANCREAS IN AIDS;Gastroenterology Clinics of North America;1997-06
3. #Hyperamylasaemia in Asymptomatic HIV Patients;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;1997-05
4. Didanosine;Drugs;1996-12
5. Pancreatic disorders in pediatric acquired immune deficiency syndrome;Human Pathology;1995-07